project id: TCGA-PAAD; case submitter id: TCGA-2J-AABE; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.79; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.04; rna integrity number: 7.6; age at index: 73; days to birth: -26943; ethnicity: not reported; gender: male; race: white; vital status: Alive; year of birth: 1939; age at diagnosis: 26943; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 676.0; icd 10 code: C25.1; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Body of pancreas; synchronous malignancy: No; tissue or organ of origin: Body of pancreas; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 0.12054794520547946; pack years smoked: 2.2; years smoked: 10.0; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 515; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-2J-AABE-01A-12; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 9.0; percent normal cells: 20.0; percent stromal cells: 65.0; percent tumor cells: 15.0; percent tumor nuclei: 15.0;